Literature DB >> 14043999

ENDOTOXIN-INDUCED TOLERANCE TO TOXIC MANIFESTATIONS OF CANDIDA ALBICANS.

H F HASENCLEVER, W O MITCHELL.   

Abstract

Hasenclever, H. F. (National Institutes of Health, Bethesda, Md.) and William O. Mitchell. Endotoxin-induced tolerance to toxic manifestations of Candida albicans. J. Bacteriol. 85:1088-1093. 1963.-Mice exposed to 425 r total body irradiation failed to become tolerant to Candida albicans toxicity after injection with lipopolysaccharide. Mice injected with lipopolysaccharide and then X-rayed did not demonstrate the tolerant state. An injection of thorium dioxide in mice that had previously received tolerance-inducing amounts of lipopolysaccharide rendered them as susceptible to acute C. albicans toxicity as control mice. A bimodal manifestation of tolerance was noted. Groups of mice given single injections of lipopolysaccharide at 6 or 1 days before challenge demonstrated high levels of tolerance, whereas the tolerance in mice given a single dose at 3 days was negligible. The bimodal effect was not observed in tolerant mice challenged with lipopolysaccharide. Injections of viable or nonviable pathogenic fungi known to produce tolerance to the toxicity of C. albicans in recipient mice did not produce tolerance to lipopolysaccharide. Serum from mice injected with lipopolysaccharide showed in vitro inhibitory activity for C. albicans.

Entities:  

Keywords:  ENDOTOXINS; EXPERIMENTAL LAB STUDY; IMMUNITY; LIPOPOLYSACCHARIDES; MICE; MONILIASIS; RADIATION EFFECTS; THORIUM

Mesh:

Substances:

Year:  1963        PMID: 14043999      PMCID: PMC278288          DOI: 10.1128/jb.85.5.1088-1093.1963

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  6 in total

1.  Symposium on bacterial endotoxins. II. Possible mechanisms whereby endotoxins evoke increased nonspecific resistance to infection.

Authors:  J L WHITBY; J G MICHAEL; M W WOODS; M LANDY
Journal:  Bacteriol Rev       Date:  1961-12

2.  Endotoxin susceptibility and delayed hypersensitivity in experimental histoplasmosis.

Authors:  E D BOX; N T BRIGGS
Journal:  J Immunol       Date:  1961-10       Impact factor: 5.422

3.  Pathogenicity of Candida.

Authors:  S MOURAD; L FRIEDMAN
Journal:  J Bacteriol       Date:  1961-04       Impact factor: 3.490

4.  Endotoxin in pathogenic q fungi.

Authors:  S B SALVIN
Journal:  J Immunol       Date:  1952-07       Impact factor: 5.422

5.  Production in mice of tolerance to the toxic manifestations of Candida albicans.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-09       Impact factor: 3.490

6.  Production of tolerance to the toxicity of Candida albicans by nonfungal materials.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1962-12       Impact factor: 3.490

  6 in total
  6 in total

Review 1.  The in vitro interactions of Candida albicans with nonspecific serum proteins.

Authors:  H F Hasenclever
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

2.  Fungal toxins as a parasitic factor responsible for the establishment of fungal infections.

Authors:  K Iwata
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

3.  IN VITRO INHIBITION OF YEAST GROWTH BY MOUSE ASCITES FLUID AND SERUM.

Authors:  D F SUMMERS; H F HASENCLEVER
Journal:  J Bacteriol       Date:  1964-01       Impact factor: 3.490

4.  Biological and chemical characterization of toxic substances from Candida albicans.

Authors:  J E Cutler; L Friedman; K C Milner
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

5.  Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity.

Authors:  E Carlson
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

6.  ACQUIRED IMMUNITY TO CANDIDIASIS IN MICE.

Authors:  H F HASENCLEVER; W O MITCHELL
Journal:  J Bacteriol       Date:  1963-09       Impact factor: 3.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.